PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells
Authors
Keywords
-
Journal
Nanomedicine
Volume 12, Issue 12, Pages 1475-1490
Publisher
Future Medicine Ltd
Online
2017-06-01
DOI
10.2217/nnm-2017-0069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model
- (2016) Seyedeh Alia Moosavian et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors
- (2016) Javad Akhtari et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Clinical Overview of MDM2/X-Targeted Therapies
- (2016) Andrew Burgess et al. Frontiers in Oncology
- Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: Production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial
- (2015) Andreas Wicki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin
- (2015) Leila Arabi et al. JOURNAL OF CONTROLLED RELEASE
- Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer
- (2014) Wenbing Dai et al. BIOMATERIALS
- Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles
- (2014) Pengfei Zhao et al. BIOMATERIALS
- P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer
- (2014) Sheida Shariat et al. CANCER LETTERS
- Tumor-Targeting Peptides and Small Molecules as Anti-Cancer Agents to Overcome Drug Resistance
- (2014) Ehsan Sarafraz-Yazdi et al. CURRENT MEDICINAL CHEMISTRY
- Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management
- (2014) Cinzia Perrino et al. Current Vascular Pharmacology
- In vivo anti-tumor activity of the organometallic ruthenium(ii)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
- (2014) Andrea Weiss et al. Chemical Science
- Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
- (2013) Roy van der Meel et al. ADVANCED DRUG DELIVERY REVIEWS
- The Thiol-Michael Addition Click Reaction: A Powerful and Widely Used Tool in Materials Chemistry
- (2013) Devatha P. Nair et al. CHEMISTRY OF MATERIALS
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
- (2013) Mark J. Ernsting et al. JOURNAL OF CONTROLLED RELEASE
- A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or Density
- (2013) Bethany Powell Gray et al. PLoS One
- Peptide-Mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Animal Models
- (2013) De-Kuan Chang et al. PLoS One
- Tumor Targeting via Integrin Ligands
- (2013) Udaya Kiran Marelli et al. Frontiers in Oncology
- Challenges in Development of Targeted Liposomal Therapeutics
- (2012) Rupa R. Sawant et al. AAPS Journal
- Nanoparticle and targeted systems for cancer therapy
- (2012) Lisa Brannon-Peppas et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances
- (2012) Shi Xu et al. ADVANCED DRUG DELIVERY REVIEWS
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Polyethylene Glycol Prevents in Vitro Aggregation of Slightly Negatively-Charged Liposomes Induced by Heparin in the Presence of Bivalent Ions
- (2012) Hiroko Shibata et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin
- (2012) Mostafa Shahin et al. CANCER LETTERS
- Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts
- (2012) Preethy Prasad et al. CANCER LETTERS
- Effective Photothermal Chemotherapy Using Doxorubicin-Loaded Gold Nanospheres That Target EphB4 Receptors in Tumors
- (2012) J. You et al. CANCER RESEARCH
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Blood–Nanoparticle Interactions and in Vivo Biodistribution: Impact of Surface PEG and Ligand Properties
- (2012) Neha B. Shah et al. MOLECULAR PHARMACEUTICS
- EGF receptor-targeted nanocarriers for enhanced cancer treatment
- (2012) Alyssa M Master et al. Nanomedicine
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Increase of lifespan for glioma-bearing rats by using minibeam radiation therapy
- (2011) Yolanda Prezado et al. JOURNAL OF SYNCHROTRON RADIATION
- Small molecule agents targeting the p53-MDM2 pathway for cancer therapy
- (2011) Weisi Wang et al. MEDICINAL RESEARCH REVIEWS
- A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems
- (2011) Lisa M. Kaminskas et al. Nanomedicine-Nanotechnology Biology and Medicine
- The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide
- (2010) Kelley A. Sookraj et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes
- (2010) E. Sarafraz-Yazdi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Her2-targeted pegylated liposomal doxorubicin: Retention of target-specific binding and cytotoxicity after in vivo passage
- (2009) Hilary Shmeeda et al. JOURNAL OF CONTROLLED RELEASE
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
- (2008) F. Gu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More